Transfusion Medicine: The Impact of Biotechnology, Growth Factors, and Bioengineering
Basic science advances coupled with sophisticated new instrumentation have been moving the discipline of Transfusion Medicine beyond its traditional role as supplier of blood components into such evolving fields as cancer cellular biotherapy, bone marrow transplantation, and gene therapy. Bioreactor culture systems, improved techniques of cell separation, and applied molecular biology are a few of the areas that promise to revolutionize transfusion practices []. However few discoveries have made the immediate impact or captured the imagination to the extent that have a series of regulatory molecules known as cytokines, interleukins, or hematopoietic growth factors.
KeywordsTransfusion Medicine Recombinant Human Erythropoietin Adoptive Immunotherapy Myeloid Growth Factor Autologous Marrow
Unable to display preview. Download preview PDF.
- 1.Chernoff AI, Klein HG, Sherman LA (eds). Research opportunities in Transfusion Medicine. Transfusion 1989;29:711–42.Google Scholar
- 15.Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophos-phamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989;74:1905–14.PubMedGoogle Scholar
- 16.Haas R, Ho AD, Bredthauer U, et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 1990:1894–98.Google Scholar